Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sanofi Ventures
company
About
Sanofi Ventures operates as the corporate venture capital arm of Sanofi.
- 1 - 10
Highlights
Details
- Industries
- Biotechnology,Financial Services,Health Care
- Founded date
- Jan 1, 1994
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- CVC
Sanofi Ventures is the corporate venture capital arm of Sanofi. We have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic interest to Sanofi. Among these areas are rare diseases, oncology, immunology and inflammation, vaccines, potential cures in other core areas of Sanofi’s business footprint, and digital health and data science solutions.
Investments
Number of Investments
Number of Lead Investments
15
4
Sanofi Ventures has made 15 investments. Their most recent investment was on
Dec 15, 2022, when Minervax raised €22M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 15, 2022
Minervax
|
Series C | €22M | Biotechnology | — |
|
Aug 2, 2022
Empatica
|
Series B | $25.94M | Artificial Intelligence | Yes |
|
Jun 29, 2022
ReCode Therapeutics
|
Series B | $120M | Biopharma | — |
|
Oct 22, 2021
Click Therapeutics
|
Series B | $52M | Biotechnology | — |
|
Oct 21, 2021
ReCode Therapeutics
|
Series B | $210M | Biopharma | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
